Carboxypeptidase B, Recombinant In Pichia Pastoris

Regulatory pressure on biopharmaceutical manufacturers continues to tighten, and one of the most straightforward ways to stay ahead is removing animal-derived materials from production workflows. Roche CustomBiotech's recombinant Carboxypeptidase B, expressed in Pichia pastoris, offers an animal-component-free alternative built for critical processes like active insulin production and antibody post-translational modification. Manufactured under DIN EN ISO 13485 and GMP guidelines, each lot is held to narrow activity and quality specifications — including ≥400 U/ml activity and ≥85% purity — so integration into existing workflows doesn't mean sacrificing consistency.

For teams looking to reduce contamination risk without overhauling their processes, this is a drop-in solution backed by dedicated regulatory and technical support from Roche.